Stock MDGEF MEDIGENE AG
Add to a list
To use this feature you must be a member
Log inSign up

News Medigene AG OTC Markets

Equities

MDGEF

DE000A1X3W00

Market Closed - OTC Markets
Other stock markets
 10:36:56 2024-03-28 am EDT 		5-day change 1st Jan Change
2.297 USD -11.96% Intraday chart for Medigene AG -5.49% +53.10%
Jul. 03 Medigene AG Expands Patent Portfolio with the Patent Grant for its NY-ESO-1/LAGE 1a Targeted T Cell Receptor in China CI
Jun. 27 Medigene Presents Efficient 6-Day TCR-T Therapy Production Process with High Stemness CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Medigene AG Expands Patent Portfolio with the Patent Grant for its NY-ESO-1/LAGE 1a Targeted T Cell Receptor in China
GL
Medigene AG Expands Patent Portfolio with the Patent Grant for its NY-ESO-1/LAGE 1a Targeted T Cell Receptor in China
CI
Medigene Presents Efficient 6-Day TCR-T Therapy Production Process with High Stemness
GL
Medigene Presents Efficient 6-Day TCR-T Therapy Production Process with High Stemness
CI
Medigene Reports Results of Annual General Meeting
GL
Medigene to Present at the Cell and Gene Therapy In-Depth Focus Summit 2024
GL
Medigene AG Announces Lead Selection for MDG2021, Expanding TCR-T KRAS Library Targeting Solid Tumors
GL
Medigene AG Announces Lead Selection for MDG2021, Expanding TCR-T KRAS Library Targeting Solid Tumors
AQ
Medigene : Expands its End to End Platform by Submitting Three Patents to the European Patent Office
PU
Medigene : Release according to Article 40, Section 1 of the WpHG
PU
Medigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology Patents to the European Patent Office
GL
Medigene, BioNTech Extend Cancer Immunotherapy Partnership
MT
Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announced Term
GL
Medigene AG's Global Research & Collaboration Agreement with BioNTech SE to Extend Beyond Initial Announced Term
CI
Medigene : Description of the remuneration system for Supervisory Board members
PU
Medigene : Report of the Executive Board on agenda item 8
PU
Medigene : Report of the Executive Board on agenda item 9
PU
Medigene : Explanations of the rights of shareholders
PU
Medigene : Proxy to third person
PU
Medigene : Data protection information
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MDG1 Stock
  4. MDGEF Stock
  5. News Medigene AG